Developer docs
API playgroundTry for free, no card

Search company profiles

AusDiagnostics

Full company profile

uuid000xdwt

Namestring
AusDiagnostics
Company typeenum
Private
Founded yearint
2006
Descriptiontext

AusDiagnostics is a private Australian manufacturer and supplier of highly multiplexed molecular diagnostics products and reagents, founded in 2006 and headquartered in Mascot, New South Wales. The company operates in the in-vitro diagnostics subsegment of the broader medical devices industry, with employee scale in the 101–250 range and a managing director (Keith Stanley) who appears to provide long-tenured leadership continuity. AusDiagnostics' stated positioning emphasizes "highly multiplexed" molecular chemistry — a technically specialized subsegment of IVD that allows many pathogens or targets to be interrogated simultaneously from a single sample, distinguishing it from singleplex assay providers.

The aggregated source material indicates an apparent partnership or distribution relationship with R-Biopharm Australia, whose catalog (r-biopharm.com.au) lists products spanning human clinical diagnostics (respiratory pathogens, gastrointestinal, sexual health, urinary tract infections, dermatophytes, drug resistance, hospital care, vector-borne infections, women's health), animal health diagnostics, applied testing, and food/feed analysis (constituents, allergens, GMOs, microbiology, mycotoxins, residues, vitamins). The technology portfolio associated with this distribution arrangement includes instruments (RIDA®Xplore, RIDA®CYCLER, RIDA®CUBE SCAN, RIDA®ABSORBANCE 96, ThunderBolt®, Pictus 500), sample-preparation kits (RIDA®Prep and RIDA®Xtract series), automated systems (CHRONECT Symbiosis RIDA®CREST), and mobile applications (RIDA®SMART APP Allergen/Mycotoxin), suggesting B2B sales into clinical pathology laboratories, food and feed testing facilities, and applied-testing customers.

Public pricing, revenue, customer-logo, and competitive-displacement data were not available in the input, so the company's revenue mechanics, contract structure, and pricing model cannot be characterized with confidence. What is clear is the business model archetype — a consumables-led molecular diagnostics manufacturer with proprietary reagents and supporting instrumentation, distributed at least in part through Australian specialty diagnostics channels.

Short descriptiontext

AusDiagnostics is an Australian manufacturer and supplier of highly multiplexed molecular diagnostics products and reagents, founded in 2006 in Mascot, serving clinical and applied testing customers through proprietary assay chemistry and instrumentation.

Operating statusenum
Unknown
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMascot, Australia
HQ citystring
Mascot
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Keyword5 values
molecular diagnostics, multiplexed PCR, diagnostic reagents, clinical diagnostics, in-vitro diagnostics
Industry1 code
PRIMARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Molecular Diagnostics
Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

AusDiagnostics manufactures and supplies highly multiplexed molecular diagnostics products and reagents, including real-time PCR instruments, automated sample preparation systems, and assay kits for pathogen, allergen, and mycotoxin detection. The portfolio is used by clinical diagnostics laboratories, food and feed testing facilities, animal health laboratories, and research institutions running high-throughput in-vitro diagnostic workflows. Complementary services include technical support, validation guidance, and instrument service delivered to laboratory customers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

R-Biopharm provides high-quality testing solutions spanning clinical diagnostics and food & feed analysis. The portfolio includes instruments (RIDA®Xplore, RIDA®CYCLER, RIDA®CUBE SCAN, RIDA®ABSORBANCE 96, ThunderBolt®, Picto 500), sample preparation kits (RIDA®Prep series, RIDA®Xtract series), technology platforms (RIDA®Xplore Alliance, RIDA®Jump Alliance), mobile applications (RIDA®SMART APP Allergen, RIDA®SMART APP Mycotoxin), and automated systems (CHRONECT Symbiosis RIDA®CREST). The diagnostics division covers human health areas (dermatophytes, gastrointestinal, respiratory pathogens, hospital care, drug resistance, sexual health, urinary tract infections, women's health, vector-borne infections) and animal health. The food & feed analysis division addresses constituents, food adulteration, allergens, GMOs, microbiology, mycotoxins, and residues.

Product and service19 records
1RIDA®Xplore
CategoryDiagnostic Instruments
Description

Automated molecular diagnostics instrument used by laboratories to run multiplexed PCR assays for pathogen, allergen, and analyte detection.

2RIDA®CYCLER
CategoryDiagnostic Instruments
Description

Real-time PCR thermal cycler for running multiplexed molecular diagnostic assays in clinical and applied testing laboratories.

3RIDA®CUBE SCAN
CategoryDiagnostic Instruments
Description

Absorbance scanner used in lateral-flow and ELISA-based diagnostic workflows alongside R-Biopharm/AusDiagnostics test kits.

4RIDA®ABSORBANCE 96
CategoryDiagnostic Instruments
Description

96-well plate absorbance reader for quantitative ELISA and end-point immunoassay workflows in diagnostic laboratories.

5ThunderBolt®
CategoryDiagnostic Instruments
Description

Molecular diagnostics instrument used to perform multiplexed real-time PCR detection in research and applied testing settings.

6Pictus 500
CategoryDiagnostic Instruments
Description

Real-time PCR instrument supporting molecular diagnostic assay runs in clinical and research laboratories.

7CHRONECT Symbiosis RIDA®CREST
CategoryDiagnostic Instruments
Description

Automated sample-handling and LC-MS interface system that couples sample preparation to chromatographic detection for food and feed safety testing.

8RIDA®SMART BOX
CategoryDiagnostic Instruments
Description

Smart instrument for rapid allergen and mycotoxin lateral-flow test evaluation in food and feed testing laboratories.

9RIDA®Xtract 24
CategorySample Preparation
Description

Automated 24-sample nucleic acid extraction system used to prepare clinical, food, and animal samples for downstream PCR testing.

10RIDA®Xtract 96
CategorySample Preparation
Description

High-throughput 96-sample nucleic acid extraction platform for laboratories running high-volume molecular diagnostic workflows.

11RIDA®Xtract 24 Pathogen Kit
CategorySample Preparation Reagents
Description

Reagent kit for automated pathogen nucleic acid extraction on the RIDA®Xtract 24 system, used prior to multiplexed PCR detection.

12RIDA®Xtract 24 Blood DNA Kit
CategorySample Preparation Reagents
Description

Reagent kit for automated DNA extraction from blood samples on the RIDA®Xtract 24 platform for downstream diagnostic testing.

13RIDA®Xtract 96 DNA/RNA Kit
CategorySample Preparation Reagents
Description

Reagent kit for high-throughput DNA and RNA extraction on the RIDA®Xtract 96 system, supporting multiplexed PCR workflows.

14RIDA®Prep Tissue Digestion Kit
CategorySample Preparation Reagents
Description

Sample preparation kit for tissue digestion prior to nucleic acid extraction in molecular diagnostic workflows.

15RIDA®PrepX Stool Kit
CategorySample Preparation Reagents
Description

Stool sample preparation kit used to extract nucleic acids from fecal samples for downstream gastrointestinal pathogen PCR testing.

16RIDA®UNITY
CategoryDiagnostic Software
Description

Software/data management offering for diagnostic laboratories to manage, interpret, and report molecular test results.

17BioQuant
CategoryDiagnostic Software
Description

Quantitative data analysis tool used in molecular diagnostic workflows to evaluate PCR and assay results.

18RIDA®Xplore Alliance
CategoryDiagnostic Instruments
Description

Integrated molecular diagnostics platform based on the RIDA®Xplore instrument, supporting multiplexed assay workflows for laboratories.

19RIDA®Jump Alliance
CategoryDiagnostic Instruments
Description

Integrated molecular diagnostics platform providing standardized, scalable multiplexed PCR workflows for diagnostic laboratories.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-sized specialty IVD manufacturer focused on molecular diagnostics (ELITe InGenius, MGB assays) and clinical chemistry — closely comparable specialty multiplex IVD company.

TypeBroad incumbent
Description

Large global molecular diagnostics / sample-prep leader (QIAamp, QIAstat-Dx, QuantiFeron) with multiplex assay panels and consumables across human and applied testing — broadly comparable to AusDiagnostics' integrated IVD manufacturing footprint but at significantly greater scale.

TypeDirect peer
Description

Korea-based specialist in multiplex molecular diagnostics (Allplex assays) covering respiratory, GI, STI, and drug-resistance panels — direct head-to-head competitor in syndromic multiplex real-time PCR testing.

TypeBroad incumbent
Description

Established life-science research and clinical diagnostics manufacturer offering multiplex digital-PCR (ddPCR) platforms and sample-prep kits; competes with AusDiagnostics in the broader molecular diagnostics and lab consumables market.

TypeDirect peer
Description

German parent group that owns the R-Biopharm product portfolio (RIDA® kits and instruments) appearing in the source data; operates the exact same clinical-IVD and food/feed-testing kit lines, and is therefore the closest direct comp to AusDiagnostics' distribution and manufacturing scope.

TypeBroad incumbent
Description

Global in vitro diagnostics leader with BioFire FilmArray syndromic panels and industrial microbiology solutions spanning human, animal, and food testing — competes on the molecular diagnostics side of AusDiagnostics' portfolio.

TypeBroad incumbent
Description

Diagnostics franchise (Panther, Aptima, Panther Fusion) dominating women's health and molecular STI testing — directly overlaps with AusDiagnostics' sexual health and women's health assay categories.

TypeBroad incumbent
Description

Now owns the Luminex multiplex bead-based assay franchise (xMAP) which competes with high-throughput multiplex molecular and immunoassay platforms at the core of AusDiagnostics' technology stack.

TypeRegional player
Description

Australian-headquartered molecular diagnostics specialist in syndromic enteric and respiratory panels (EasyScreen) — the closest home-market peer for AusDiagnostics operating in the same Australian laboratory channel.

TypeBroad incumbent
Description

Owner of the GeneXpert rapid molecular testing platform with syndromic panels (Xpress, Respiratory, CT/NG) — global incumbent in clinical molecular diagnostics competing head-to-head in hospital lab channels.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AusDiagnostics

Molecular Diagnosticsausdiagnostics.com

AusDiagnostics is an Australian manufacturer and supplier of highly multiplexed molecular diagnostics products and reagents, founded in 2006 in Mascot, serving clinical and applied testing customers through proprietary assay chemistry and instrumentation.

What AusDiagnostics does

AusDiagnostics is a private Australian manufacturer and supplier of highly multiplexed molecular diagnostics products and reagents, founded in 2006 and headquartered in Mascot, New South Wales. The company operates in the in-vitro diagnostics subsegment of the broader medical devices industry, with employee scale in the 101–250 range and a managing director (Keith Stanley) who appears to provide long-tenured leadership continuity. AusDiagnostics' stated positioning emphasizes "highly multiplexed" molecular chemistry — a technically specialized subsegment of IVD that allows many pathogens or targets to be interrogated simultaneously from a single sample, distinguishing it from singleplex assay providers.

The aggregated source material indicates an apparent partnership or distribution relationship with R-Biopharm Australia, whose catalog (r-biopharm.com.au) lists products spanning human clinical diagnostics (respiratory pathogens, gastrointestinal, sexual health, urinary tract infections, dermatophytes, drug resistance, hospital care, vector-borne infections, women's health), animal health diagnostics, applied testing, and food/feed analysis (constituents, allergens, GMOs, microbiology, mycotoxins, residues, vitamins). The technology portfolio associated with this distribution arrangement includes instruments (RIDA®Xplore, RIDA®CYCLER, RIDA®CUBE SCAN, RIDA®ABSORBANCE 96, ThunderBolt®, Pictus 500), sample-preparation kits (RIDA®Prep and RIDA®Xtract series), automated systems (CHRONECT Symbiosis RIDA®CREST), and mobile applications (RIDA®SMART APP Allergen/Mycotoxin), suggesting B2B sales into clinical pathology laboratories, food and feed testing facilities, and applied-testing customers.

Public pricing, revenue, customer-logo, and competitive-displacement data were not available in the input, so the company's revenue mechanics, contract structure, and pricing model cannot be characterized with confidence. What is clear is the business model archetype — a consumables-led molecular diagnostics manufacturer with proprietary reagents and supporting instrumentation, distributed at least in part through Australian specialty diagnostics channels.

AusDiagnostics firmographics

Firmographics
Name
AusDiagnostics
Website
https://ausdiagnostics.com
Company type
Private
Founded year
2006
Operating status
Unknown
Headcount range
51–100 employees
Short description
AusDiagnostics is an Australian manufacturer and supplier of highly multiplexed molecular diagnostics products and reagents, founded in 2006 in Mascot, serving clinical and applied testing customers through proprietary assay chemistry and instrumentation.
Ownership category
akta.pro rank

AusDiagnostics industry classification

Industry
Product category
Molecular Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)

Keywords

  • Molecular diagnostics
  • Multiplexed PCR
  • Diagnostic reagents
  • Clinical diagnostics
  • In-vitro diagnostics

Where AusDiagnostics is headquartered

Location

Headquarters

HQ city
Mascot
HQ country
Australia
HQ region
Oceania

Markets served

AusDiagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

AusDiagnostics product offering

Product offering

Core offering

AusDiagnostics manufactures and supplies highly multiplexed molecular diagnostics products and reagents, including real-time PCR instruments, automated sample preparation systems, and assay kits for pathogen, allergen, and mycotoxin detection. The portfolio is used by clinical diagnostics laboratories, food and feed testing facilities, animal health laboratories, and research institutions running high-throughput in-vitro diagnostic workflows. Complementary services include technical support, validation guidance, and instrument service delivered to laboratory customers.

Product overview

R-Biopharm provides high-quality testing solutions spanning clinical diagnostics and food & feed analysis. The portfolio includes instruments (RIDA®Xplore, RIDA®CYCLER, RIDA®CUBE SCAN, RIDA®ABSORBANCE 96, ThunderBolt®, Picto 500), sample preparation kits (RIDA®Prep series, RIDA®Xtract series), technology platforms (RIDA®Xplore Alliance, RIDA®Jump Alliance), mobile applications (RIDA®SMART APP Allergen, RIDA®SMART APP Mycotoxin), and automated systems (CHRONECT Symbiosis RIDA®CREST). The diagnostics division covers human health areas (dermatophytes, gastrointestinal, respiratory pathogens, hospital care, drug resistance, sexual health, urinary tract infections, women's health, vector-borne infections) and animal health. The food & feed analysis division addresses constituents, food adulteration, allergens, GMOs, microbiology, mycotoxins, and residues.

Differentiator

Problem solved

Functional benefit

Products and services

  • RIDA®Xplore Automated molecular diagnostics instrument used by laboratories to run multiplexed PCR assays for pathogen, allergen, and analyte detection.
  • RIDA®CYCLER Real-time PCR thermal cycler for running multiplexed molecular diagnostic assays in clinical and applied testing laboratories.
  • RIDA®CUBE SCAN Absorbance scanner used in lateral-flow and ELISA-based diagnostic workflows alongside R-Biopharm/AusDiagnostics test kits.
  • RIDA®ABSORBANCE 96 96-well plate absorbance reader for quantitative ELISA and end-point immunoassay workflows in diagnostic laboratories.
  • ThunderBolt® Molecular diagnostics instrument used to perform multiplexed real-time PCR detection in research and applied testing settings.
  • Pictus 500 Real-time PCR instrument supporting molecular diagnostic assay runs in clinical and research laboratories.
  • CHRONECT Symbiosis RIDA®CREST Automated sample-handling and LC-MS interface system that couples sample preparation to chromatographic detection for food and feed safety testing.
  • RIDA®SMART BOX Smart instrument for rapid allergen and mycotoxin lateral-flow test evaluation in food and feed testing laboratories.
  • RIDA®Xtract 24 Automated 24-sample nucleic acid extraction system used to prepare clinical, food, and animal samples for downstream PCR testing.
  • RIDA®Xtract 96 High-throughput 96-sample nucleic acid extraction platform for laboratories running high-volume molecular diagnostic workflows.
  • RIDA®Xtract 24 Pathogen Kit Reagent kit for automated pathogen nucleic acid extraction on the RIDA®Xtract 24 system, used prior to multiplexed PCR detection.
  • RIDA®Xtract 24 Blood DNA Kit Reagent kit for automated DNA extraction from blood samples on the RIDA®Xtract 24 platform for downstream diagnostic testing.
  • RIDA®Xtract 96 DNA/RNA Kit Reagent kit for high-throughput DNA and RNA extraction on the RIDA®Xtract 96 system, supporting multiplexed PCR workflows.
  • RIDA®Prep Tissue Digestion Kit Sample preparation kit for tissue digestion prior to nucleic acid extraction in molecular diagnostic workflows.
  • RIDA®PrepX Stool Kit Stool sample preparation kit used to extract nucleic acids from fecal samples for downstream gastrointestinal pathogen PCR testing.
  • RIDA®UNITY Software/data management offering for diagnostic laboratories to manage, interpret, and report molecular test results.
  • BioQuant Quantitative data analysis tool used in molecular diagnostic workflows to evaluate PCR and assay results.
  • RIDA®Xplore Alliance Integrated molecular diagnostics platform based on the RIDA®Xplore instrument, supporting multiplexed assay workflows for laboratories.
  • RIDA®Jump Alliance Integrated molecular diagnostics platform providing standardized, scalable multiplexed PCR workflows for diagnostic laboratories.

Companies that use AusDiagnostics

Customer profile

Ideal customer profiles1 record

AusDiagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AusDiagnostics partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights3 records

AusDiagnostics competitors and assessment

Company assessment

Direct peers

  • ELITech Group: Mid-sized specialty IVD manufacturer focused on molecular diagnostics (ELITe InGenius, MGB assays) and clinical chemistry — closely comparable specialty multiplex IVD company.
  • Seegene: Korea-based specialist in multiplex molecular diagnostics (Allplex assays) covering respiratory, GI, STI, and drug-resistance panels — direct head-to-head competitor in syndromic multiplex real-time PCR testing.
  • R-Biopharm AG: German parent group that owns the R-Biopharm product portfolio (RIDA® kits and instruments) appearing in the source data; operates the exact same clinical-IVD and food/feed-testing kit lines, and is therefore the closest direct comp to AusDiagnostics' distribution and manufacturing scope.

Broad incumbents

  • QIAGEN: Large global molecular diagnostics / sample-prep leader (QIAamp, QIAstat-Dx, QuantiFeron) with multiplex assay panels and consumables across human and applied testing — broadly comparable to AusDiagnostics' integrated IVD manufacturing footprint but at significantly greater scale.
  • Bio-Rad Laboratories: Established life-science research and clinical diagnostics manufacturer offering multiplex digital-PCR (ddPCR) platforms and sample-prep kits; competes with AusDiagnostics in the broader molecular diagnostics and lab consumables market.
  • bioMérieux: Global in vitro diagnostics leader with BioFire FilmArray syndromic panels and industrial microbiology solutions spanning human, animal, and food testing — competes on the molecular diagnostics side of AusDiagnostics' portfolio.
  • Hologic: Diagnostics franchise (Panther, Aptima, Panther Fusion) dominating women's health and molecular STI testing — directly overlaps with AusDiagnostics' sexual health and women's health assay categories.
  • DiaSorin (formerly Luminex): Now owns the Luminex multiplex bead-based assay franchise (xMAP) which competes with high-throughput multiplex molecular and immunoassay platforms at the core of AusDiagnostics' technology stack.
  • Cepheid (Danaher): Owner of the GeneXpert rapid molecular testing platform with syndromic panels (Xpress, Respiratory, CT/NG) — global incumbent in clinical molecular diagnostics competing head-to-head in hospital lab channels.

Regional players

  • Genetic Signatures: Australian-headquartered molecular diagnostics specialist in syndromic enteric and respiratory panels (EasyScreen) — the closest home-market peer for AusDiagnostics operating in the same Australian laboratory channel.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

AusDiagnostics social profiles

Digital presence

AusDiagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AusDiagnostics leadership team

Management profile

Number of profiles

Profiles1 record

AusDiagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AusDiagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AusDiagnostics

What does AusDiagnostics do?

AusDiagnostics manufactures and supplies highly multiplexed molecular diagnostics products and reagents, including real-time PCR instruments, automated sample preparation systems, and assay kits for pathogen, allergen, and mycotoxin detection. The portfolio is used by clinical diagnostics laboratories, food and feed testing facilities, animal health laboratories, and research institutions running high-throughput in-vitro diagnostic workflows. Complementary services include technical support, validation guidance, and instrument service delivered to laboratory customers.

Is AusDiagnostics a public or private company?

AusDiagnostics is a private company. It is classified as unknown and is currently unknown.

When was AusDiagnostics founded?

AusDiagnostics was founded in 2006. It employs 51 to 100 people.

Where is AusDiagnostics based?

AusDiagnostics is headquartered in Mascot, Australia, in the Oceania region.

Who are AusDiagnostics's main competitors?

Direct peers on record are ELITech Group, Seegene and R-Biopharm AG. Broad incumbents are QIAGEN, Bio-Rad Laboratories, bioMérieux, Hologic, DiaSorin (formerly Luminex) and Cepheid (Danaher). Genetic Signatures is listed as a regional player.

Does AusDiagnostics have an API?

No public API is recorded for AusDiagnostics.

What industry is AusDiagnostics in?

AusDiagnostics's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals